| 2019 ESC guidelines for the management of patients with supraventricular tachycardia the task force for the management of patients with supraventricular tachycardia of the … J Brugada, DG Katritsis, E Arbelo, F Arribas, JJ Bax, ... European heart journal 41 (5), 655-720, 2020 | 1032 | 2020 |
| Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry G Boriani, M Proietti, C Laroche, L Fauchier, F Marin, M Nabauer, ... EP Europace 21 (7), 1013-1022, 2019 | 62 | 2019 |
| Diagnosis and management of left atrial appendage thrombus in patients with atrial fibrillation undergoing cardioversion or percutaneous left atrial procedures: results of the … MM Farkowski, K Jubele, F Marín, E Gandjbakhch, P Ptaszynski, ... EP Europace 22 (1), 162-169, 2020 | 42 | 2020 |
| Investigation on sudden unexpected death in the young (SUDY) in Europe: results of the European Heart Rhythm Association Survey ER Behr, C Scrocco, AAM Wilde, E Marijon, L Crotti, KE Iliodromitis, ... EP Europace 24 (2), 331-339, 2022 | 31 | 2022 |
| The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation: a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists L Fauchier, D Angoulvant, GYH Lip EP Europace 17 (5), 671-673, 2015 | 25 | 2015 |
| Contemporary management of patients with syncope in clinical practice: an EHRA physician-based survey GA Dan, D Scherr, K Jubele, MM Farkowski, K Iliodromitis, G Conte, ... EP Europace 22 (6), 980-987, 2020 | 15 | 2020 |
| Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term … WY Ding, M Proietti, G Boriani, L Fauchier, C Blomström-Lundqvist, ... EP Europace 24 (5), 721-728, 2022 | 14 | 2022 |
| Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general … VL Malavasi, M Vitolo, M Proietti, I Diemberger, L Fauchier, F Marin, ... European journal of clinical investigation 52 (7), e13773, 2022 | 9 | 2022 |
| Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry WY Ding, TS Potpara, C Blomström‐Lundqvist, G Boriani, F Marin, ... European journal of clinical investigation 52 (6), e13745, 2022 | 9 | 2022 |
| Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry WY Ding, A Kotalczyk, G Boriani, F Marin, C Blomström-Lundqvist, ... European journal of internal medicine 103, 41-49, 2022 | 6 | 2022 |
| Contemporary clinical management of monomorphic idiopathic premature ventricular contractions: results of the European Heart Rhythm Association survey A Sorgente, MM Farkowski, K Iliodromitis, JM Guerra, K Jubele, JKR Chun, ... EP Europace 24 (6), 1006-1014, 2022 | 5 | 2022 |
| Sinus rhythm maintenance after electrical cardioversion for atrial fibrillation in high-risk patients—comparative efficacy of antiarrhythmic medications B Kokina, A Strēlnieks, I Pupkeviča, K Jubele, M Vikmane, S Sakne, ... Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact …, 2021 | 5 | 2021 |
| Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry M Vitolo, VL Malavasi, M Proietti, I Diemberger, L Fauchier, F Marin, ... European journal of internal medicine 99, 45-56, 2022 | 4 | 2022 |
| Rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an EHRA survey AC Schwab, A Anic, MM Farkowski, J Guerra, KE Iliodromitis, K Jubele, ... Europace 25 (2), 676-681, 2023 | 3 | 2023 |
| Impact of body mass index on parameters of the left atrium: cardiac computed tomography study V Verhovceva, L Zvaigzne, K Jubele, O Kalējs Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact …, 2022 | 2 | 2022 |
| Antithrombotic treatment management in low stroke risk patients undergoing cardioversion of atrial fibrillation< 48 h duration: results of an EHRA survey F Migliore, R Providencia, MM Farkowski, GA Dan, S Daniel, TS Potpara, ... EP Europace 23 (9), 1502-1507, 2021 | 2 | 2021 |
| PO358 The Oral Anticoagulant Influence on Health-Related Quality of Life for High-Risk Atrial Fibrillation Patients N Nesterovics, I Pupkevica, K Apsite, M Ventina, K Jubele, O Kalejs, ... Global Heart 13 (4), 456, 2018 | 1 | 2018 |
| Comparison of dabigatran and rivaroxaban versus warfarin in patients with persistent and long-standing atrial fibrillation undergoing electrical cardioversion with high risk of … O Kalejs, K Jubele, A Strelnieks, I Sime, I Cgojeva-Sproge, G Kamzola, ... Circulation 134 (suppl_1), A19980-A19980, 2016 | 1 | 2016 |
| A case report of pulmonary vein isolation performed in a patient with polysplenia and interrupted inferior vena cava K Kupics, K Jubele, G Nesterovics, A Erglis European Heart Journal-Case Reports 5 (12), ytab480, 2021 | | 2021 |
| Impact of malignancy on outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General … VL Malavasi, M Vitolo, M Proietti, L Fauchier, F Marin, M Nabauer, ... European Heart Journal 42 (Supplement_1), ehab724. 2862, 2021 | | 2021 |
